Immunoassay Analyzers Market Research Report- Forecast till 2032

Immunoassay Analyzers Market Research Report Information By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), By Application (Infectious Diseases, Autoimmune Diseases, AIDS), By End-User (Hospitals) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

ID: MRFR/MED/0694-HCR | 80 Pages | Author: Kinjoll Dey | June 2023         

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Immunoassay Analyzer Market, by Instrument

6.1 Introduction

6.2 Immunofluorescence

Market Estimates & Forecast, 2023-2032

6.3 Chemiluminescence

Market Estimates & Forecast, 2023-2032

6.4 ELISA

Market Estimates & Forecast, 2023-2032

6.5 Multiplexed Assay System

Market Estimates & Forecast, 2023-2032

6.6 Radioimmunoassay

Market Estimates & Forecast, 2023-2032

6.7 Others

Chapter 7. Global Immunoassay Analyzer Market, by Application

7.1 Introduction

7.2 Infectious Diseases

Market Estimates & Forecast, 2023-2032

7.3 Autoimmune Diseases

Market Estimates & Forecast, 2023-2032

7.4 AIDS

Market Estimates & Forecast, 2023-2032

7.5 Endocrinology

Market Estimates & Forecast, 2023-2032

7.6 Drug Monitoring

Market Estimates & Forecast, 2023-2032

7.7 Cardiology

Market Estimates & Forecast, 2023-2032

7.8 Oncology

Market Estimates & Forecast, 2023-2032

7.9 Allergy Testing

Market Estimates & Forecast, 2023-2032

7.10 Others

Chapter 8 Global Immunoassay Analyzer Market, by End User

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, 2023-2032

8.3 Diagnostic Laboratories

Market Estimates & Forecast, 2023-2032

8.4 Research Institutes

Market Estimates & Forecast, 2023-2032

8.5 Others

Chapter 9. Global Immunoassay Analyzer Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 F. Hoffmann-La Roche Ltd

11.1.1 Company Overview

11.1.2 Instrument Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Siemens Ltd.

11.2.1 Company Overview

11.2.2 Instrument Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Abbott

11.3.1 Company Overview

11.3.2 Instrument Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Beckman Coulter, Inc.

11.4.1 Company Overview

11.4.2 Instrument/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Biokit S.A

11.5.1 Company Overview

11.5.2 Instrument Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Immunodiagnostic Systems

11.6.1 Company Overview

11.6.2 Instrument Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Merck KGaA

11.7.1 Overview

11.7.2 Instrument Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Medical Devices Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Immunoassay Analyzer Industry Synopsis, 2023-2032

Table 2 Global Immunoassay Analyzer Market Estimates and Forecast, 2023-2032, (USD Million)

Table 3 Global Immunoassay Analyzer Market by Region, 2023-2032, (USD Million)

Table 4 Global Immunoassay Analyzer Market by Instruments, 2023-2032, (USD Million)

Table 5 Global Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 6 Global Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 7 North America Immunoassay Analyzer Market by Instruments, 2023-2032, (USD Million)

Table 8 North America Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 9 North America Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 10 US Market by Instruments, 2023-2032, (USD Million)

Table 11 US Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 12 US Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 13 Canada Market by Instruments, 2023-2032, (USD Million)

Table 14 Canada Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 15 Canada Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 16 South America Market by Instruments, 2023-2032, (USD Million)

Table 17 South America Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 18 South America Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 19 Europe Market by Instruments, 2023-2032, (USD Million)

Table 20 Europe Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 21 Europe Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 22 Western Europe Market by Instruments, 2023-2032, (USD Million)

Table 23 Western Europe Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 24 Western Europe Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 25 Eastern Europe Market by Instruments, 2023-2032, (USD Million)

Table 26 Eastern Europe Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 27 Eastern Europe Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 28 Asia Pacific Market by Instruments, 2023-2032, (USD Million)

Table 29 Asia Pacific Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 30 Asia Pacific Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

Table 31 Middle East & Africa Market by Instruments, 2023-2032, (USD Million)

Table 32 Middle East & Africa Immunoassay Analyzer Market by Application, 2023-2032, (USD Million)

Table 33 Middle East & Africa Immunoassay Analyzer Market by End Users, 2023-2032, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Immunoassay Analyzer Market

Figure 3 Segmentation Market Dynamics for Global Immunoassay Analyzer Market

Figure 4 Global Immunoassay Analyzer market Share, by Instrument 2020

Figure 5 Global Immunoassay Analyzer market Share, by Application 2020

Figure 6 Global Immunoassay Analyzer Market Share, by End Users, 2020

Figure 7 Global Immunoassay Analyzer Market Share, by Region, 2020

Figure 8 North America Immunoassay Analyzer Market Share, by Country, 2020

Figure 9 Europe Immunoassay Analyzer Market Share, by Country, 2020

Figure 10 Asia Pacific Immunoassay Analyzer Market Share, by Country, 2020

Figure 11 Middle East & Africa Immunoassay Analyzer Market Share, by Country, 2020

Figure 12 Global Immunoassay Analyzer Market: Company Share Analysis, 2020 (%)

Figure 13 F. Hoffmann-La Roche Ltd.: Key Financials

Figure 14 F. Hoffmann-La Roche Ltd.: Segmental Revenue

Figure 15 F. Hoffmann-La Roche Ltd.: Geographical Revenue

Figure 16 Siemens Ltd.: Key Financials

Figure 17 Siemens Ltd.: Segmental Revenue

Figure 18 Siemens Ltd.: Geographical Revenue

Figure 19 Abbott: Key Financials

Figure 20 Abbott: Segmental Revenue

Figure 21 Abbott: Geographical Revenue

Figure 22 Beckman Coulter, Inc.: Key Financials

Figure 23 Beckman Coulter, Inc.: Segmental Revenue

Figure 24 Beckman Coulter, Inc.: Geographical Revenue

Figure 25 Biokit S.A: Key Financials

Figure 26 Biokit S.A: Segmental Revenue

Figure 27 Biokit S.A: Geographical Revenue

Figure 28 Immunodiagnostic Systems: Key Financials

Figure 29 Immunodiagnostic Systems: Segmental Revenue

Figure 30 Immunodiagnostic Systems: Geographical Revenue

Figure 31 Merck KGaA: Key Financials

Figure 32 Merck KGaA: Segmental Revenue

Figure 33 Merck KGaA: Geographical Revenue

Immunoassay Analyzers Market Segmentation


Immunoassay Analyzers Instruments Outlook (USD Billion, 2018-2032)




  • Immunofluorescence




  • Chemiluminescence




  • ELISA




  • Radioimmunoassay




Immunoassay Analyzers Application Outlook (USD Billion, 2018-2032)




  • Infectious Diseases




  • Autoimmune Diseases




  • AIDS




Immunoassay Analyzers End User Outlook (USD Billion, 2018-2032)




  • Hospitals




Immunoassay Analyzers Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • North America Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • North America Immunoassay Analyzers by End User








  • Hospitals







    • US Outlook (USD Billion, 2018-2032)




    • US Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay









  • US Immunoassay Analyzers by Application








      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS





    • US Immunoassay Analyzers by End User







  • Hospitals







    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • CANADA Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • CANADA Immunoassay Analyzers by End User







  • Hospitals






  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Europe Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Europe Immunoassay Analyzers by End User








  • Hospitals







    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Germany Immunoassay Analyzers Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Germany Immunoassay Analyzers by End User







  • Hospitals







    • France Outlook (USD Billion, 2018-2032)




    • France Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • France Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • France Immunoassay Analyzers by End User







  • Hospitals







    • UK Outlook (USD Billion, 2018-2032)




    • UK Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • UK Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • UK Immunoassay Analyzers by End User







  • Hospitals







    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence






    • ITALY Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • ITALY Immunoassay Analyzers by End User







  • Hospitals







    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Spain Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Spain Immunoassay Analyzers by End User







  • Hospitals







    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • REST OF EUROPE Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • REST OF EUROPE Immunoassay Analyzers by End User







  • Hospitals






  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Asia-Pacific Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS














    • Asia-Pacific Immunoassay Analyzers by End User







  • Hospitals







    • China Outlook (USD Billion, 2018-2032)




    • China Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • China Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • China Immunoassay Analyzers by End User







  • Hospitals







    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Japan Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Japan Immunoassay Analyzers by End User







  • Hospitals







    • India Outlook (USD Billion, 2018-2032)




    • India Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • India Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • India Immunoassay Analyzers by End User







  • Hospitals







    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Australia Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Australia Immunoassay Analyzers by End User







  • Hospitals







    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Rest of Asia-Pacific Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Rest of Asia-Pacific Immunoassay Analyzers by End User







  • Hospitals






  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Rest of the World Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Rest of the World Immunoassay Analyzers by End User








  • Hospitals







    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Middle East Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Middle East Immunoassay Analyzers by End User







  • Hospitals







    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Africa Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Africa Immunoassay Analyzers by End User







  • Hospitals







    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Immunoassay Analyzers by Instruments




      • Immunofluorescence




      • Chemiluminescence




      • ELISA




      • Radioimmunoassay






    • Latin America Immunoassay Analyzers by Application




      • Infectious Diseases




      • Autoimmune Diseases




      • AIDS






    • Latin America Immunoassay Analyzers by End User





  • Hospitals



Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid